Promimic licensee, Onkos Surgical, receives FDA clearance of new addition to Limb Salvage System, marking the entry of HA<sup>nano</sup> Surface<sup>®</sup> into the large joint implant market with a system that…
Read morePromimic AB (publ), the world’s leading innovator in nano surface modification, is pleased to announce the recent Innovasis, Inc. special 510(k) clearance from the U.S. Food and Drug Administration (FDA)…
Read moreThe first spinal device utilizing HAnano Surface to improve osseointegration has now been 510(k) approved by the FDA. Through partnership with Promimic, Cutting Edge Spine developed the EVOL SI Sacroiliac…
Read morePromimic AB (publ) Announces Partnership with Onkos Surgical® for Development of Hydroxyapatite Surface Technology (HAnano Surface®) in Limb Salvage Surgery. Promimic AB (publ), the world’s leading innovator in nano surface…
Read moreGOTHENBURG, NOVEMBER 02, 2018 Promimic will be present at the ASTM workshop on coatings for the Medical Device industry in Washington on the 6th of November. Per Kjellin, one of…
Read morePer Kjellin earned a PhD in chemistry at Chalmers and now runs Promimic – a company which manufactures surface layers for implants. By developing an innovative surface layer for…
Read moreGOTEHNBURG – December 14, 2017. Promimic announces that the Food and Drug Administration (FDA) has approved our HAnano Surface for use on dental implants in the USA with our partners…
Read morePromimic is proud to announce that its new office, based in Austin, Texas, has opened. It is headed by the former CEO of Promimic Ulf Brogren, who will lead Promimic’s…
Read moreGOTHENBURG – January 17, 2017. Promimic today announces that the Board of Directors has appointed a new CEO, Mr. Magnus Larsson, who will start his assignment in January, 2017. Mr….
Read moreGOTHENBURG – October 27, 2016. Promimic today announces that the company has elected Tord Lendau as Chairman of the Board of Directors, and Håkan Krook and Patrik Sjöstrand as Non-executive…
Read more